Skip to Main Content

Paper Details

Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer.
Sci Rep
2
2023
Author NameAffiliation
Hans-Peter SinnUniversity Hospital of Heidelberg
  • 1 - 1

Datasets

Release 1.2